Black Rock Inc. Sqz Biotechnologies CO Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.27 - $0.68 $15,695 - $39,529	-58,132 Reduced 47.34%	64,677 $17,000
Q1 2023 May 12, 2023	BUY	$0.53 - $0.87 $327 - $537	618 Added 0.51%	122,809 $68,000
Q4 2022 Feb 13, 2023	SELL	$0.67 - $2.85 $104,528 - $444,637	-156,013 Reduced 56.08%	122,191 $90,000
Q3 2022 Nov 14, 2022	SELL	$2.16 - $3.48 $18,215 - $29,346	-8,433 Reduced 2.94%	278,204 $635,000
Q2 2022 Aug 12, 2022	SELL	$2.77 - $5.0 $3.03 Million - $5.47 Million	-1,094,818 Reduced 79.25%	286,637 $910,000
Q1 2022 May 12, 2022	SELL	$4.01 - $10.42 $129,984 - $337,764	-32,415 Reduced 2.29%	1,381,455 $6.65 Million
Q4 2021 Feb 10, 2022	BUY	$8.93 - $14.85 $1.46 Million - $2.43 Million	163,780 Added 13.1%	1,413,870 $12.6 Million
Q3 2021 Nov 09, 2021	BUY	$11.46 - $15.77 $391,232 - $538,372	34,139 Added 2.81%	1,250,090 $18 Million
Q2 2021 Aug 11, 2021	BUY	$11.32 - $14.45 $13.8 Million - $17.6 Million	1,215,951 New	1,215,951 $17.6 Million

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.